top
Please input keywords
OK
Database
Family Website
Eucure Biopharma
Biocytogen Boston Corp.
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Partnerships
Pipeline
RenMice™ HiTS Platform
Technology
Antibody discovery platforms
Antibody drug R&D
RenMice
Models
Animal/cell Models
Disease Models
Gene Editing
Investor Relations
Home
Technology
Technologies
Unlocking competitive edge through integrated innovation
Bispecific Antibody Platform
RenLite common light-chain mouse platform, bispecific antibody assembly platform, and streamlined discovery process
More
Bispecific ADC Platform
Streamlined RenLite-based bsADC discovery process for 200+ TAA
More
TCR-Mimic Antibody Platform
TCRm antibodies for intracellular targets
More
GPCR Technology Platform
GPCR antibody discovery and screening supported by target knockout RenMice and target humanized mice.
More
Step 1
Antibody Discovery
Fully human antibody discovery...
Leveraging our proprietary fully human antibody mice, including RenMice (RenMab, RenLite, and RenNan...
More
Step 2
Preclinical Research
Preclinical Pharmacology Evalu...
We design robust in vivo and in vitro study models to evaluate the efficacy and safety of candidate...
More
Step 3
Translational Research
Large Animal Translational Res...
In comparison to implanted mouse tumor models, spontaneous tumors in larger animals, especially cani...
More
Step 4
Clinical Development
Clinical Development
The Eucure clinical development team is highly experienced in drug development both domestically and...
More